You will move to an external webpage. Are you sure?

Nobelpharma

News & Press Release

  • 2003-07-01 Announcements

Commencement of clinical development（July – December）／Developmental Pharmaceutical Products No. 2 and 3 determined・NPC-02: Zinc preparation (Wilson’s disease)・NPC-03: Injection-based Phenobarbital (neonatal seizure and status epilepticus )

  1. 前の記事へ
  2. 一覧へ戻る（英語）
  3. 次の記事へ
PAGE TOP
  1. HOME
  2. News & Press Release
  3. Commencement of clinical development（July – December）／Developmental Pharmaceutical Products No. 2 and 3 determined・NPC-02: Zinc preparation (Wilson’s disease)・NPC-03: Injection-based Phenobarbital (neonatal seizure and status epilepticus )